Media Coverage Archive 2019

Media Coverage

Media Coverage Archive 2019

This page contains a listing of news items featuring Fred Hutch. Older items may be located in the archive to the left.

GeekWire, Feb. 7, 2019
GeekWire mentioned Fred Hutch’s work with Microsoft on helping cancer patients better track their treatment side effects.
GeekWire, Feb. 4, 2019
Kathy Alexion’s new role as Fred Hutch’s CIO was announced in GeekWire’s weekly tech moves column. Alexion previously supported former CIO Matthew Trunnell since 2016.
FierceBiotech, Feb. 4, 2019
This article features recent HIV research from Fred Hutch Drs. Jesse Bloom and Julie Overbaugh. Researchers have created an atlas of immune-evading mutations HIV mutations, providing insight on the functional interactions between antibodies and HIV.
Everyday Health, Feb. 4, 2019
Fred Hutch researcher Stephen Schwartz provides expert commentary on a study published in The Lancet Public Health on obesity and cancer.
The Guardian, Feb. 3, 2019
This article features research led by Fred Hutch researcher Dr. Anne McTiernan showing that women who exercised for 45 minutes in the morning 5 days a week reported 70 percent better sleep than before the study.
KIRO 7 TV, Jan. 31, 2019
Fred Hutch Dr. Trevor Bedford comments on the value of the Seattle Flu Study.
GeekWire, Jan. 31, 2019
Dr. Veena Shankaran’s new role as the co-director of Fred Hutch’s healthcare economics and policy group was announced in GeekWire’s weekly tech moves column.
Cascadia Magazine, Jan. 30, 2019
Fred Hutch researcher Drs. Keith Jerome, Hans-Peter Kiem and Michael Louella, who coordinates the research group’s Community Advisory Board, provide expert comments on the importance of community engagement in HIV research.
Q13 Fox, Jan. 29, 2019
Fred Hutch researcher Dr. Anne McTiernan provided expert commentary on the value of exercise for those who have breast cancer.
Q13 Fox, Jan. 29, 2019
Fred Hutch researcher Dr. Anne McTiernan is featured in this segment for her research on exercise in relation to breast cancer prevention. Dr. McTiernan found that moderate exercise, 45 minutes a day, 5 days a week, can reduce breast cancer risk by as much as 20%.
Reuters Health – MD Linx, Jan. 28, 2019
This article features Fred Hutch researcher Dr. Parth Shah’s latest research on HPV vaccination. Dr. Shah found that parents were more confident in HPV vaccination and more motivated to have their child vaccinated by being exposed to physician messages that provided information rather than a sense of urgency.
POZ, Jan. 25, 2019
This article highlights a recent study which found a high rate of undiagnosed acute and chronic hepatitis among cancer patients. Fred Hutch researcher Dr. Scott Ramsey provides expert commentary on the implications the study has in terms of screening. U.S. News & World Report also covered this study.
Managed Care Online , Jan. 25, 2019
Fred Hutch researcher Dr. Gary Lyman is featured in this Q&A piece on biosimilars. Dr. Lyman provides comments about how the high prices of cancer treatment contribute to financial toxicity.
GeekWire, Jan. 23, 2019
This story features the Seattle Flu Study, a new project from the Brotman Baty Institute which was co-founded by Seattle Children’s, UW Med and Fred Hutch. The study will look at 10,000 swabs to better understand how the flu spreads and how to prevent it. Fred Hutch’s Dr. Trevor Bedford is the lead data scientist for the study.
The Seattle Times, Jan. 23, 2019
This article includes a mention of a Fred Hutch study led by Dr. Marian Neuhouser which found that women diagnosed with breast cancer who ate a low-fat diet were more likely to survive.
Forbes, Jan. 21, 2019
Dr. Cyrus Ghajar’s latest research on metastatic breast cancer is the focus of this piece. Dr. Ghajar’s work details how to kill dormant breast cancer cells in their sleep. Several other outlets including GeekWire, KOMO-TV and FireceBiotech also covered this news.
ABC News (Australia), Jan. 17, 2019
Dr. Geoffrey Hill and collaborators in Australia discovered how a common virus called cytomegalovirus reactivates in transplantation patients. In a study published in Science, the researchers found that strain-specific antibodies made from B cells are responsible for keeping CMV suppressed in mice, without the need for any other immune cells.
CURE Today, Jan. 16, 2019
This article features Dr. Joseph Unger’s recent study in JAMA Oncology on clinical trial participation. Dr. Unger shows that patients with comorbidities are less likely to participate in clinical trials.
Men’s Health, Jan. 14, 2019
This piece highlights a study published in JNCI by Fred Hutch Dr. Joseph Unger, which shows that men who’ve taken 5-alpha reductase inhibitors had a 21 percent reduced risk of PCa 16 years later.
Becker’s Hospital Review, Jan. 11, 2019
This piece features Fred Hutch Dr. Joseph Unger’s latest research showing that expanding clinical trial eligibility criteria to allow patients with comorbidities would give opportunities for up to 6,317 cancer patients to be allowed to join a trial every year.
GeekWire, Jan. 11, 2019
Fred Hutch researcher Dr. Steve Pergam is featured as GeekWire’s ‘Geek of the Week’. Dr. Pergam is an associate member of the Vaccine and Infectious Disease Division at Fred Hutch.
ecancer, Jan. 11, 2019
Fred Hutch researcher Dr. Joseph Unger’s latest research on clinical trial participation is featured in this piece. Dr. Unger and his team showed that cancer patients with other illnesses or conditions, are less likely to be offered to join a clinical trial, and therefore less likely to enroll. This research was published in several other outlets including Healio, Medical Health News and MedPage Today.
CURE Today, Jan. 5, 2019
Fred Hutch Dr. Filippo Milano in featured in this Q&A piece about how cord blood is used for transplants.